Evaluation of BiCROS Fitting Benefits

June 10, 2025 updated by: Sonova AG

Evaluate the Benefit of a BiCROS Hearing Aid Fitting

22 candidates for BiCROS hearing aids will be recruited and fitted with a hearing aid and a CROS device. Following a real-world trial, each participant will be tested on a range of outcome measures including speech recognition in noise, ratings of listening effort, and ratings of preference.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Unilateral Hearing Loss (UHL) can be defined as any degree of permanent hearing loss on one ear with normal hearing in the opposite ear. Unilateral hearing loss can be debilitating associated with audiological, psychosocial and educational challenges. Audiological challenges include the reduced ability to localize sounds, reduced awareness on the unaidable side and difficulties hearing in noise or at a distance.

One solution for unaidable UHL is Contralateral Routing of Signals (CROS) and Bilateral Contralateral routing of signals (BiCROS) using a so-called CROS transmitter together with a hearing aid.

The rationale for this clinical investigation is to collect clinical data with a rechargeable CROS transmitter to evaluate the benefits of a BiCROS fitting compared to the alternative treatment option, the monaural hearing aid fitting, and to no treatment in noisy listening situations.

Hearing tests, ear impressions and hearing aid fitting visits are mainly conducted at the National Centre for Audiology in London, Ontario. Those visits are available at the Sonova Innovation Centre Toronto in Mississauga, Ontario, upon request. Outcome measurements are only conducted at the National Centre for Audiology in London, Ontario.

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • London, Ontario, Canada, N6G 1H1
        • National Centre for Audiology
      • Mississauga, Ontario, Canada, L5L1J3
        • Sonova Innovation Centre Toronto

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 99 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • unaidable hearing loss in worse ear (>N6)
  • aidable hearing loss (N3 to N5) on the other ear
  • fluent English speaker

Exclusion Criteria:

- aidable hearing loss in both ears

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: BiCROS fitting with beamformer
Each participant will be fitted with the experimental CROS device on the unaidable ear and with a compatible hearing aid on the other ear. A beamformer (directional microphone) will be enabled during this measurement. Although each ear receives a different device configuration depending on the condition, the participant is assigned as a whole, and assignment is not by ears.
A participant will wear a hearing aid with and without a CROS device on the unaidable ear.
Experimental: BiCROS fitting omni
Each participant will be fitted with the experimental CROS device on the unaidable ear and with a compatible hearing aid on the other ear. The microphones will be omnidirectional. Although each ear receives a different device configuration depending on the condition, the participant is assigned as a whole, and assignment is not by ears.
A participant will wear a hearing aid with and without a CROS device on the unaidable ear.
Active Comparator: Monaural hearing aid fitting with beamformer
Each participant will be fitted with a hearing aid on the better hearing ear and no device on the unaidable ear. A beamformer (directional microphone) will be enabled during the measurement. Although each ear receives a different device configuration depending on the condition, the participant is assigned as a whole, and assignment is not by ears.
A participant will wear a hearing aid with and without a CROS device on the unaidable ear.
Active Comparator: Monaural hearing aid fitting omni
Each participant will be fitted with a hearing aid on the better hearing ear and no device on the unaidable ear. The microphone will be omnidirectional. Although each ear receives a different device configuration depending on the condition, the participant is assigned as a whole, and assignment is not by ears.
A participant will wear a hearing aid with and without a CROS device on the unaidable ear.
No Intervention: Unaided condition
No intervention, the participants are not fitted with a CROS device and/or hearing aid.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Speech Intelligibility in Noise Measured With US Matrix Test (Noise From a Defined Loudspeaker)
Time Frame: At the appointment following the 4 weeks home trial each participant went on wearing the BiCROS fitting

Measuring the Signal to Noise Ratio change in decibels (dB) for speech from the front loudspeaker and noise from the better ear's side with the US matrix Test. Results of the speech test will be the SRT (speech recognition threshold) in dB SNR (signal to noise ratio).

The target speaker will be presented from 0° azimuth and is adaptive (start level at 65dB (A)).

The noise will be presented on the better ear at an azimuth of 90° or 270° (depending on the site of the better ear), at a level of 65 dB (A).

At the appointment following the 4 weeks home trial each participant went on wearing the BiCROS fitting

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Speech Intelligibility in Noise Measured With US Matrix Test (Diffuse Noise)
Time Frame: At the appointment following the 4 weeks home trial each participant went on wearing the BiCROS fitting

Measuring the Signal to Noise Ratio change in decibels (dB) for speech from the front loudspeaker in surrounding noise with the US Matrix Test. Results of the speech test will be the SRT (speech recognition threshold) in dB SNR (signal to noise ratio).

The target speaker will be presented from 0° azimuth and is adaptive (start level at 65dB (A).

The noise will be presented from a circle of 8 surrounding speakers from 45° to 315° at a level of 65 dB (A) with the participant seated in the centre of the circle.

At the appointment following the 4 weeks home trial each participant went on wearing the BiCROS fitting
Reports of Subjective Quality of Hearing as Assessed by the SSQ
Time Frame: At the appointment following the 4 weeks home trial each participant went on wearing the BiCROS fitting
Measured after home trial with the Speech, Spatial and Qualities of Hearing Scale-Benefit (Gatehouse, 2004). The scale ranges from -5 to 5, where negative values indicate that the condition under test is worse than the comparator, 0 indicates no change, and positive values indicate a benefit of the condition under test compared to the comparator.
At the appointment following the 4 weeks home trial each participant went on wearing the BiCROS fitting
Reports of Subjective Quality of Hearing as Assessed by the Bern Benefit Questionnaires
Time Frame: At the appointment following the 4 weeks home trial each participant went on wearing the BiCROS fitting
Measured after home trial with the Bern Benefit in Single-Sided Deafness Questionnaire (Komps et al, 2011). The scale ranges from -5 to 5, where negative values indicate that the condition under test is better wihtout the hearing aid, 0 indicates no change, and positive values indicate a benefit with the hearing aid.
At the appointment following the 4 weeks home trial each participant went on wearing the BiCROS fitting
Sound Quality Ratings for Total Impression and Clarity Using Gabriellson et al (1990) Ratings Scales
Time Frame: At the appointment following the 4 weeks home trial each participant went on wearing the BiCROS fitting
Ratings of speech in noise presented via loudspeakers using Gabriellson et al (1990) Ratings Scales. Scales include Clarity and Total Impression, and range from 1 to 10. The higher the rating, the better the Clarity and Total Impression.
At the appointment following the 4 weeks home trial each participant went on wearing the BiCROS fitting
Subjective Preference of Hearing Aid Condition
Time Frame: At the appointment following the 4 weeks home trial each participant went on wearing the BiCROS fitting
3 alternative forced choice (A, B, no preference or ABX) paradigm with three repetitions for speech in noise presented via loudsepakers
At the appointment following the 4 weeks home trial each participant went on wearing the BiCROS fitting
Listening Effort in Noise Using 7 Point Scale (Holmes et. al., 2018)
Time Frame: At the appointment following the 4 weeks home trial each participant went on wearing the BiCROS fitting
Measuring listening effort for speech in multi-talker babble presented via loudspeaker. The scale ranges from 1 to 7, and a higher rating indicates less listening effort.
At the appointment following the 4 weeks home trial each participant went on wearing the BiCROS fitting

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Susan Scollie, Western University, Canada

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 11, 2022

Primary Completion (Actual)

March 21, 2023

Study Completion (Actual)

March 21, 2023

Study Registration Dates

First Submitted

April 8, 2022

First Submitted That Met QC Criteria

May 12, 2022

First Posted (Actual)

May 18, 2022

Study Record Updates

Last Update Posted (Actual)

June 11, 2025

Last Update Submitted That Met QC Criteria

June 10, 2025

Last Verified

March 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Unilateral Deafness

Clinical Trials on Hearing aid fitting

Subscribe